General Information of the Compound
Compound ID |
CP0005026
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3-[4-(1-formylpiperazin-4-yl)benzylidenyl]-2-indolinone
Show/Hide
|
||||||||||||||||||
Synonyms |
(Z)-4-(4-((2-Oxoindolin-3-ylidene)methyl)phenyl)piperazine-1-carbaldehyde
186610-89-9
3[4-(1-Formylpiperazin-4-yl)benzylidenyl]-2-indolinone
4-[4-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]phenyl]piperazine-1-carbaldehyde
AC1NZT45
BDBM50065306
CHEMBL315546
SCHEMBL141892
SU-4984
SU4984
ZINC12832813
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C20H19N3O2
|
||||||||||||||||||
Molecular Weight |
333.391
|
||||||||||||||||||
Canonical SMILES |
O=CN1CCN(CC1)c1ccc(\C=C2/C(=O)Nc3ccccc23)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C20H19N3O2/c24-14-22-9-11-23(12-10-22)16-7-5-15(6-8-16)13-18-17-3-1-2-4-19(17)21-20(18)25/h1-8,13-14H,9-12H2,(H,21,25)/b18-13-
Show/Hide
|
||||||||||||||||||
InChIKey |
ZNFJBJDODKHWED-AQTBWJFISA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( SU4984 )
Drug Name | SU4984 |
---|